Institutional Sign In

Go

Pilulka

Pilulka's net profit fell 156% yoy to CZK -65.7 mil in 2022

By Helgi Library - May 25, 2023

Pilulka made a net profit of CZK -65.7 mil in 2022, down 156% compared to the previous year. Total sales reached CZK 2,465 mil, ...

Pilulka's net profit fell 156% yoy to CZK -65.7 mil in 2022

By Helgi Library - May 25, 2023

Pilulka made a net profit of CZK -65.7 mil with revenues of CZK 2,465 mil in 2022, down by 156% and up by 2.16%, re...

Pilulka's employees rose 5.51% yoy to 383 in 2022

By Helgi Library - May 25, 2023

Pilulka employed 383 employees in 2022, up 5.51% compared to the previous year. Historically, between 2018 and 2022, ...

Profit Statement
Balance Sheet
Ratios
Valuation

Get all company financials in excel:

Download Sample   $19.99

Get all company financials in excel:

Download Sample   $19.99

Pilulka's price/earnings (P/E) rose 84.9% yoy to -24.9 in 2022

By Helgi Library - May 25, 2023

Pilulka stock traded at CZK 650 per share at the end 2022 translating into a market capitalization of USD 74.7 mil. Since the end of 2017, stock has appreciated by 0% representing an annual average growth of %. In absolute terms, the value of the compan...

Pilulka's ROCE fell 66.7% yoy to -30.2% in 2022

By Helgi Library - May 25, 2023

Pilulka made a net profit of CZK -65.7 mil in 2022, down 156% compared to the previous year. Historically, between 2018 and 2022, the company's net profit reached a high of CZK -25.6 mil in 2020 and a low of CZK -65.7 mil in 2022. The result implies a ret...

Pilulka's Capital Expenditures rose 12.2% yoy to CZK 69.3 mil in 2022

By Helgi Library - May 25, 2023

Pilulka invested a total of CZK 69.3 mil in 2022, down 12.2% compared to the previous year. Historically, between 2018 - 2022, the company's investments stood at a high of CZK 78.9 mil in 2021 and a low of CZK 26.4 mil in 2020. As a p...

Pilulka's Net Margin fell 150% yoy to -2.66% in 2022

By Helgi Library - May 25, 2023

Pilulka made a net profit of CZK -65.7 mil with revenues of CZK 2,465 mil in 2022, down by 156% and up by 2.16%, respectively, compared to the previous year. This translates into a net margin of -2.66%. Historically, between 2018 and 2022, the firmâ...

Pilulka's Net Profit per Customer fell 145% yoy to USD -4.03 in 2022

By Helgi Library - May 24, 2023

Pilulka made a net profit of CZK -65.7 mil with revenues of CZK 2,465 mil in 2022, down by 156% and up by 2.16%, respectively, compared to the previous year. This translates into a net margin of -2.66%. On the operating level, EBITDA reached CZK -0.744 mil,...

Pilulka's P/FCF rose 77.8% yoy to -14.3 in 2022

By Helgi Library - May 25, 2023

Pilulka stock traded at CZK 650 per share at the end 2022 translating into a market capitalization of USD 74.7 mil. Since the end of 2017, the stock has appreciated by 0% representing an annual average growth of %. At the end of 2022, the firm traded at ...

Pilulka's Net Debt/EBITDA fell 3,845% yoy to -73.8 in 2022

By Helgi Library - May 25, 2023

Pilulka's net debt stood at CZK 54.9 mil and accounted for 39.2% of equity at the end of 2022. The ratio is up 65.7 pp compared to the previous year. Historically, the firm’s net debt to equity reached a high of 486% in 2018 and a low of -47....

Pilulka's Share Price fell 61.4% yoy to CZK 650 in 2022

By Helgi Library - May 25, 2023

Pilulka stock traded at CZK 650 per share at the end 2022 implying a market capitalization of USD 74.7 mil. Since the end of 2017, stock has appreciated by % implying an annual average growth of % In absolute terms, the value of the company rose by U...

More News

Pilulka Logo

Finance

Pilulka has been growing its sales by a year on average in the last 5 years. EBITDA has grown by 0% during that time to total of in 2050, or of sales. That’s compared to % average margin seen in last five years.

The company netted in 2050 implying ROE of and ROCE of . Again, the average figures were % and %, respectively when looking at the previous 5 years.

Pilulka’s net debt amounted to at the end of 2050, or of equity. When compared to EBITDA, net debt was x, up when compared to average of x seen in the last 5 years.

Valuation

Pilulka stock traded at per share at the end of 2050 resulting in a market capitalization of . Over the previous five years, stock price grew by 0% or % a year on average. The closing price put stock at a 12-month trailing EV/EBITDA of x and price to earnings (PE) of x as of 2050.